[Female sexual dysfunction and multiple sclerosis: A case-control study]. / Dysfonction sexuelle féminine et sclérose en plaques : étude cas-témoins.

OBJECTIVES: To compare the scores of the different dimensions of sexual function of women with multiple sclerosis to a group of control women and to identify possible factors associated with sexual dysfunction in women with multiple sclerosis. METHODS: This is a descriptive and analytical case-control study. Twenty-six women with multiple sclerosis were compared to 26 control women matched for age and socioeconomic status. The evaluation focused on demographic and clinical data. Patients with multiple sclerosis were evaluated by Expanded Disability Status Scale (EDSS) for functional status, by Female Sexual Function Inventory (FSFI) for sexual function and by Beck Depression Inventory-Short Form (BDI-DF) for severity of depression. RESULTS: Our results confirmed the high prevalence of sexual dysfunction among patients with multiple sclerosis (69.2%) compared to controls (26.9%) (P=0.002). Sexual desire, arousal and orgasm were the most altered sexual phases in our study. Total FSFI, and FSFI subscale scores (sexual desire, arousal, lubrication, orgasm and satisfaction) were lower in women with multiple sclerosis compared with controls. The analytical study showed that in women with multiple sclerosis, the total FSFI score was correlated with age (rs=-0.68; P<0.001), duration of marriage (rs=-0.57; P=0.002), level of disability (rs=-0.45; P=0.021) and BDI-SF score (rs=-0.51; P=0.008). FSFI score was also associated to low education level (P=0.02) and urinary dysfunction (P=0.04). CONCLUSION: Our study highlighted the importance of sexual dysfunction in women with multiple sclerosis. The inclusion of this aspect in the clinical assessment will improve the quality of life of these patients. LEVEL OF EVIDENCE: 3.

[Rethink the panic disorder]. / Repenser le trouble panique.

INTRODUCTION: We propose some reflexions on the validity of the conceptualization of panic disorder, its nosographical place, and its clinical homogeneity, through the study of the frequency of some of its psychiatric comorbidities. BACKGROUND: To define a panic attack, DSM IV requires a number of symptoms which vary from four to 13. However, some patients suffer from panic attacks with less than four symptoms (paucisymptomatic attacks) and which fill the other criteria of panic disorder. These patients would have a biological vulnerability, familial antecedents, and a treatment response which are similar to those that fill the criteria of the panic attack according to the DSM. Some authors differentiate the panic disorder in several sub-groups, such as the panic disorder with cardiorespiratory symptoms, or vestibular symptoms, or cognitive symptoms. This division of the panic disorder in several sub-groups would have an interest in the knowledge of the etiopathogeny, the attacks' frequency, the disorder severity and the treatment response. Panic disorder with prevalent somatic expression includes crises without cognitive symptoms. This sub-type can be common in the medical context, especially in cardiology, but it is often ignored, at the price of loss of socio-professional adaptability, and a medical overconsumption. DISCUSSION AND ARGUMENTS: The relationship between panic disorder and agoraphobia appears to be the subject of controversies. According to the behavioral theory, phobic disorder is the primum movens of the sequence of appearance of the disorders. American psychiatry considers agoraphobia as a secondary response to the panic disorder, and pleads for a central role of panic attacks as an etiopathogenic factor in the development of agoraphobia. The distinction between panic disorder and generalized anxiety disorder can be difficult. This is due to the existence of paucisymptomatic panic attacks. Their paroxystic nature is difficult to distinguish from the fluctuations of the generalized anxiety disorder. This frequent comorbidity could be also due to the community of certain symptoms of each disorder. These observations increase the validity of the anxiety generalized disorder as an autonomous morbid entity, rather than corresponding to a residual syndrome of the panic disorder, and could be an argument of an implicit return to the Freudian concept of the anxiety neurosis. The frequent comorbidity of panic disorder and personality disorders suggests the existence of a link. The pathological personality can be a factor of vulnerability in the panic disorder, as it can be a consequence of the panic disorder through the personality changing related on the evolution of the disorder and its complications. The relationship between panic disorder and depression has been interpreted in various ways, with mainly three assumptions: the unit position, which considers anxiety and depression as concerning a common diathesis; the dualistic position, which suggests that anxiety and depression are heterogeneous diagnostic categories and the anxio-depressive position that considers anxiety and depression combined as a syndrome differing from the pure anxiety and pure depression. The genetic studies, as well as the family studies, clearly show that the two entities are undissociated. Likewise, the therapeutic action of serotoninergic antidepressants in the two types of disorders reinforces the idea of a common biological vulnerability between anxiety and depression. Several studies have shown a significant association between panic disorder and suicide. However, the suicidal conducts are multiple and proceed by complex interactions between factors of features and states. Accordingly, panic disorder can be considered as a factor of state associated with the suicidal risk.

[Binge eating disorder and obesity: Epidemiological, clinical and psychopathological aspects. A study of an obese population in Sfax (Tunisia)]. / Hyperphagie boulimique et obésité : aspects épidémiologiques, cliniques et psychopathologiques. Etude d'une population d'obèses à Sfax (Tunisie).

OBJECTIVES: To evaluate the prevalence of binge eating disorder (BED) in a population of obese patients, to appreciate the impact of obesity on BED through a comparison between the obese group and a control group, and to assess anxiety, depression and quality of life in obese patients with BED. PATIENTS AND METHODS: A cross-sectional study including 60 obese patients and 60 controls. BED was diagnosed using the Binge Eating Scale. Quality of life was assessed by the Quality Of Life, Obesity and Dietetics Scale, and depression and anxiety symptoms by the Hospital Anxiety and Depression Scale. RESULTS: The obese group had a higher prevalence of BED than the control group (40% versus 8.3%; p < 0.001; OR = 3.5). The average score of BES was also higher (p < 0.001). Obese patients with BED were younger (p = 0.034). BED was correlated with an early onset of obesity (p = 0.01; OR = 1.12), depression (p = 0.002), anxiety (p = 0.008) and a poorer quality of life. CONCLUSION: This study confirms the relationship between obesity and BED, which is correlated with a high prevalence of anxiety and depression and with a poorer quality of life.